News Snapshot:
June 29 (UPI) -- Chinese officials announced Monday that they have approved a new COVID-19 vaccine for immediate use by military personnel. The vaccine, called Ad5-nCoV, is currently being evaluated in clinical trials. Advertisement It is unclear how many of the nearly 2.2 million people who serve in the Chinese military will receive the vaccine. Ad5-nCoV was developed as part of a collaborative effort between the Beijing Institute of Biotechnology, part of the Academy of Military Medical Sciences, which is the military's research division, and the biotechnology firm CanSino Biologics. RELATED Brazil signs $127M agreement to produce COVID-19 vaccine In...
